Introduction: Vital signs are routinely used to assess acutely ill patients, but they do not detect all patients at risk of death. This retrospective multicenter cohort study compares the prediction of death by impaired mobility with age, co-morbidities, and vital sign changes. Methods: On first assessment, patients from a combined cohort of 9684 Danish and Irish patients and a separate cohort of 1010 Ugandan patients were stratified by impaired mobility on presentation (IMOP), vital sign changes assessed by the National Early Warning Score (NEWS), the Charlson Co-morbidity Index, and age. Results: Fourteen percent of Danish and Irish patients had IMOP compared with 42% of Ugandan patients. The odds ratios of IMOP for 7-day mortality were similar for both cohorts (i.e. 11.8, 95% CI 5.8-24.0 for Ugandan patients versus 6.7, 95% CI 5.0-9.0 for Danish and Irish patients). Univariate analysis of Ugandan patients showed that none of the parameters tested (i.e. low blood pressure, pulse, elevated respiratory rate, hypothermia, low oxygen saturation, old age, and coma) had a statistically higher odds ratio for either 7-day mortality than IMOP. Multivariate logistic regression analysis of Danish and Irish patients also showed that none of these parameters or the Charlson Co-morbidity Index had a statistically higher odds ratio than IMOP for either 7-day or 30-day mortality. Conclusion: Immobility on presentation is a vital sign and predicts mortality for acutely ill patients independently of the traditional vital signs, age, and co-morbidities.
Editorial comment
There are several ways to assess a patients' risk of deterioration and death at the time of admission to hospital. This multicenter study evaluated the impact of a very simple question: is the patient able to stand, walk, or get unto the bed unaided -and found immobility to be an independent predictor of mortality.
Early reliable risk stratification of acutely unwell patients is important for the rapid provision and escalation of care. This is especially important in elderly patients with multiple comorbid conditions. Moreover, the accurate identification of patients at low risk will allow a number of emergency admissions to be managed as an outpatient. 1, 2 Risk stratification on arrival to the acute care setting is usually based on presenting complaints and vital sign changes. However, acutely ill patients who subsequently die often have vague nonspecific symptoms and vital signs that are normal or close to normal. [2] [3] [4] Normal vital signs on arrival, even if assessed by an aggregate score, do not guarantee a good outcome: some 40% of patients deteriorate 5 days after admission. 5 Other predictors of death, such as age, co-morbidities, and reduced physiological reserve must, therefore, be considered at first assessment. [6] [7] [8] [9] A simple brief assessment of impaired mobility (i.e. the ability to stand unaided) implies reduced physiological reserve and requires no equipment and little training to observe. This makes it ideal for use in the acute care setting. [10] [11] [12] In order to encourage its widespread adoption, we report in this large retrospective multicenter international study the additional prognostic value of stratifying patients by impaired mobility on presentation. The study examined markedly different cohorts of patients from both medical and surgical admission units.
Methods
This is a retrospective multicenter cohort study including six independent cohorts from four hospitals in three countries and complies with the Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD) 13 and STROBE guidelines. 14 
Patients
The first assessment performed on the first contact of each patient in each cohort was included. All assessments from subsequent potential admissions were excluded. All patients were aged 18 or older.
Settings
From Nenagh Hospital is a small rural Irish hospital. 6 We included acutely ill medical patients admitted to it between February 1999 and January 2004. 9 Lastly, we included a cohort of acutely admitted medical patients from St. Joseph's Kitovu Health Care Complex, a missionary hospital in Uganda, Africa, located near Masaka with 220 beds. The inclusion period was from July 2011 till September 2012. 15 
Data collection
All data were recorded when deemed necessary. Impaired mobility on presentation (IMOP) in the acute care setting was the only variable not recorded as standard.
At the Hospital of South West Jutland in Esbjerg, nurses were instructed to record whether the patient was able to get onto the bed unaided, either from the ambulance gurney or whichever way they arrived. At Lillebaelt Hospital in Kolding, a single study nurse extracted evidence of IMOP from the electronic records retrospectively with guidance from the main author. Cases of doubt were discussed and settled by consensus of the study nurse and the main author. We performed no estimation of inter-observer reliability. In Nenagh Hospital, patients were considered to have IMOP if they were unable to stand up unaided and in Kitovu Hospital if they were unable to walk without help.
Assessment of coma and other co-morbidities
Coma was defined as having a motor response only to pain or being unresponsive. 16 As a measure of other co-morbidities, we calculated the Charlson co-morbidity index, an aggregate of 19 co-morbidities known to be predictive of mortality 17 : in Irish patients, it was calculated from data entered into a prospectively collected database and in Danish patients using the Danish National Patient Register. 18 No co-morbidity data were available for Kitovu patients.
Assessment of vital signs
Instead of assessing deviation of each individual vital sign, we used the UK National Early Warning Score (NEWS) as a marker of vital sign abnormality. 19 NEWS is an aggregate of vital sign abnormalities (blood pressure, pulse, respiratory rate, temperature, oxygen saturation, use of supplementary oxygen, and mental status), where each vital signs is assigned a value corresponding to its level of abnormality. A cutoff of two NEWS points or less was chosen as this score excluded all patients with coma.
Outcome measures
Seven and 30-day mortality.
Follow-up
Follow-up on Danish patients was completed through the Danish Civil Register ensuring complete follow-up. 20 Follow-up of Irish patients was completed by personally contacting all patients who had not re-attended the health service within 1 year of discharge and whose death had not been registered while Ugandan patients only had in-hospital follow-up.
Ethics
All data collection in all cohorts conformed to the principles outlined in the Declaration of Helsinki. 21 Under Danish law, retrospective register studies are exempt from the need for approval by an ethics committee. The study was approved by the Danish Authorities for Health and Medicines and the Danish Data Protection Agency. Ethical approval was also not required for this retrospective study in either Ireland or Uganda.
Statistics
Data are presented as medians (range) or proportions (95% confidence interval). The effect of IMOP, age, and co-morbidity were examined by uni-and multivariate logistic regression. In case of missing data, patients were excluded from analysis, except for the calculation of the Charlson Co-morbidity Index. Stata 14.1 was used for analyses (Stata Corp LP, College Station, TX, USA).
Results
The study population was 14,441 patients: median age 59 years (range 18-103 years) and 7486 (52%) were women. A total of 323 (2.2%) patients died within 7 days and 654 (4.5%) died within 30 days. NEWS could be calculated for 10,751 (74.4%) of the patients, IMOP was available for 14,113 (97.7%) and both in the final study population of 10,694 (Table 1) . Overall, the proportion of patients with IMOP was 17%, but varied widely in the four separate Patients from Kitovu Hospital were analyzed as a separate cohort from the Danish and Irish patients: not only did more of them have IMOP, but they were also younger, had a higher NEWS score, had a higher mortality rate, more were lost to follow-up and, almost certainly, they suffered from completely different conditions and received a different standard of care. Despite these differences, the increased mortality associated with IMOP 7 days after admission was similar in both cohorts with overlapping 95% confidence intervals : i.e. odds ratio of 11.8 (95% CI 5.8-24.0) for Kitovu patients and 6.7 (95% CI 5.0-9.0) for Danish and Irish patients.
NEWS further stratified patients into four distinct prognostic groups in both the Danish and Irish cohort (Fig. 1 ) and Kitovu patients: the only group of Kitovu patients that had a significantly different 7-day mortality from Danish and Irish patients were those with IMOP and a NEWS >2 (Table 2) .
Univariate analysis of Danish and Irish patients combined showed that the only unadjusted odds ratios for 7-day mortality for low systolic blood pressure and low oxygen saturation were higher than that of IMOP; only the unadjusted odds ratio for low blood pressure was higher for 30-day mortality (Table 3) . Multivariate logistic regression analysis showed IMOP was an independent predictor of mortality, and that none of the other parameters tested (i.e. low blood pressure, pulse, elevated respiratory rate, hypothermia, low oxygen saturation, old age, coma or Charlson Co-morbidity Index) had a significantly higher odds ratio for either 7-day or 30-day mortality than IMOP. Insufficient follow-up data were available to allow univariate analysis of Kitovu patients for 30-day mortality; tachypnea, hypothermia, and age had a lower unadjusted odds ratio than IMOP for 7-day mortality, while the odds ratios for hypotension, high and low pulse rate, low oxygen saturation, and coma were all comparable to that of IMOP with overlapping confidence intervals.
Discussion
This large retrospective multicenter international study shows that impaired mobility on presentation (IMOP) is a key predictor of outcome in acutely unwell patients, with a similar performance in widely different patient populations. Even though overall 14% of European patients had IMOP compared with 42% of patients in Uganda, their odds ratio for 7 day mortality were similar.
Patients with IMOP and a NEWS ≥3 were four times more likely to die within 7 days than mobile patients with a NEWS ≥3, and patients with IMOP were three times more likely to have a NEWS ≥3. IMOP is easy, rapid, reliable, and cheap to assess. Only significantly deranged vital signs (profound hypotension, severe hypoxia, and loss of consciousness) were comparable to IMOP at predicting mortality. However, IMOP is more frequent than any of these other factors. Moreover, IMOP was a more powerful predictor of 30-day mortality than age and co-morbidity and is, therefore, better than either of them at improving the risk stratification of vital signs.
Currently, vital signs (alone or aggregated into early warning scores) are used to predict mortality and the need for critical care admission. 22, 23 Once vital signs become abnormal, clinical deterioration may already be in progress. The variation of the predictive performance of vital signs in certain disease groups 10, 24, 25 is probably because they only measure of how the body is coping with the current state of illness, rather than its capacity to cope with stresses and challenges in the future. In contrast, IMOP may predict that there will be reduced physiological reserve available to cope with stresses and challenges later in the course of the patient's illness.
Although some independent vital signs were comparable predictors of mortality, none are as easily and quickly obtainable or as prevalent as IMOP. Other studies have shown that the addition of mobility assessment to early warning scores improves their discrimination. 10, 11, 26 Our study confirms these findings: logistic regression showed IMOP to be a major determinant of 30-day mortality, whereas other measures classically used in early warning scores were less powerful predictors.
Unfortunately, there are major limitations to this retrospective study. Our data were collected over different time periods, and IMOP could only be assessed by retrospective chart review at Kolding Hospital. Moreover, the assessment of IMOP was not uniform in the different cohorts. Missing data were a major problem: in the multivariable analyses, the sample size drops by about half, and as a result of missing data, not all our cohorts were consecutive admissions. The major limitation, however, is that we could not determine retrospectively whether impaired mobility was acute, temporary or permanent after admission, and how many patients with impaired mobility had longstanding conditions such as severe arthritis or degenerative neurological disease. The only group of Kitovu patients that had a significantly different 7-day mortality from Danish and Irish patients were those with IMOP and a NEWS >2: this might be explained by the lower quality and intensity of care available to Ugandan patients, or it might be that more Ugandan patients had acquired IMOP as a result of their acute severe illness, whereas in more of the much older Danish and Irish patients, IMOP was from the gradual onset of frailty or chronic disease. Physiological reserve reduces progressively with age and one of its common manifestations is frailty. 27 Assessing frailty can be complex, and there is a lack of consensus on its definition and identification. 28, 29 None of the existing frailty assessment tools reliably distinguish frail from nonfrail patients in the acute care setting. 30 Moreover, frailty classifications can differ substantially depending on the assessment tool used, 31, 32 and there is overlap between frailty, co-morbidity, and disability. 33 However, using IMOP is a reasonable pragmatic approach for patients in acute settings as even those who have chronic impairment when they are well are likely to become more impaired when they are acutely ill.
Conclusion
In this large study of divergent populations of acutely ill patients, IMOP was a powerful predictor of mortality that was independent of age, co-morbidities, and traditional vital signs. IMOP should be used as a vital sign as it quickly, easily, and cheaply improves the risk stratification of acutely ill patients.
